Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia
Authors:
- 2 April 2021
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 29 (10) , 6127-6134
Abstract
Purpose We evaluated the preventive effect of the antioxidant edaravone (EDR) on chemotherapy-induced alopecia (CIA) to improve quality of life in cancer patients. Methods Hair loss was induced by intraperitoneally administering cyclophosphamide (CPA, 75 mg/kg) to rats, and topically applying EDR ointment (100 mg/day) once daily for 16 days (when hair loss starts) or 21 days (just before hair growth). The rats were divided into four groups: control group (without CPA or EDR), EDR 0% group (CPA + EDR 0%), EDR 3% group (CPA + EDR 3%), and EDR 30% group (CPA + EDR 30%). The prevention of CIA was evaluated by the hair coverage score (five levels from 0 to 4). Furthermore, we measured the size of the hair follicle area and the expression levels of insulin-like growth factor (IGF)-1 mRNA in dermal papilla cells. Results The EDR 3% and EDR 30% groups exhibited higher hair coverage scores than the EDR 0% group on day 16 and day 21. On day 16, the hair follicle area in the EDR 3% and EDR 30% groups was significantly larger than that in the EDR 0% group. Furthermore, IGF-1 expression levels in the EDR 3% group were significantly higher than those in the EDR 0% group. On day 21, no significant difference was observed in hair follicle area or IGF-1 mRNA levels among the groups. Conclusion Our results show that EDR administration lessened hair loss due to CPA in a dose-independent manner above doses of 3%, suggesting potential applications beside chemotherapy.Keywords
This publication has 21 references indexed in Scilit:
- A novel rat model for chemotherapy-induced alopeciaClinical and Experimental Dermatology, 2012
- The α-Lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: A pilot studySurgery Today, 2011
- IGF-I Signalling Controls the Hair Growth Cycle and the Differentiation of Hair ShaftsJournal of Investigative Dermatology, 2005
- A Guide to Assessing Damage Response Pathways of the Hair Follicle: Lessons From Cyclophosphamide-Induced Alopecia in MiceJournal of Investigative Dermatology, 2005
- Chemotherapy-induced alopecia: psychosocial impact and therapeutic approachesSupportive Care in Cancer, 2004
- A Comprehensive Guide for the Accurate Classification of Murine Hair Follicles in Distinct Hair Cycle StagesJournal of Investigative Dermatology, 2001
- Control of hair growth and follicle size by VEGF-mediated angiogenesisJournal of Clinical Investigation, 2001
- Reduction of Intrafollicular Apoptosis in Chemotherapy-Induced Alopecia by Topical Calcitriol-AnalogsJournal of Investigative Dermatology, 1998
- The Role of IGF-I in Human Skin and its Appendages: Morphogen as Well as Mitogen?Journal of Investigative Dermatology, 1997
- Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production.Journal of Clinical Investigation, 1988